Lower ß2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
Deepak Cyril D'Souza, M.D.; Irina Esterlis, Ph.D.; Michelle Carbuto, B.A.; Maegan Krasenics, B.A.; John Seibyl, M.D.; Frederic Bois, Ph.D.; Brian Pittman, M.S.; Mohini Ranganathan, M.D.; Kelly Cosgrove, Ph.D.; Julie Staley, Ph.D.
From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.
Am J Psychiatry 2012;169:326-334.
doi:10.1176/appi.ajp.2011.11020189
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.